KR20030069216A - 히스타민 수용체 길항제 - Google Patents

히스타민 수용체 길항제 Download PDF

Info

Publication number
KR20030069216A
KR20030069216A KR10-2003-7009493A KR20037009493A KR20030069216A KR 20030069216 A KR20030069216 A KR 20030069216A KR 20037009493 A KR20037009493 A KR 20037009493A KR 20030069216 A KR20030069216 A KR 20030069216A
Authority
KR
South Korea
Prior art keywords
histamine
receptor
antagonist
asthma
antagonists
Prior art date
Application number
KR10-2003-7009493A
Other languages
English (en)
Korean (ko)
Inventor
젠킨슨스티븐
오레일리마크앤터니
트레베씨크마이클앤드류
Original Assignee
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드 filed Critical 화이자 인코포레이티드
Publication of KR20030069216A publication Critical patent/KR20030069216A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2003-7009493A 2001-01-17 2002-01-10 히스타민 수용체 길항제 KR20030069216A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0101223.6 2001-01-17
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
KR20030069216A true KR20030069216A (ko) 2003-08-25

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7009493A KR20030069216A (ko) 2001-01-17 2002-01-10 히스타민 수용체 길항제

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2858647B1 (en) 2012-06-08 2018-05-23 Sensorion H4 receptor inhibitors for treating tinnitus

Also Published As

Publication number Publication date
BR0206502A (pt) 2003-10-21
EP1353657A1 (en) 2003-10-22
NO20033223L (no) 2003-07-16
WO2002056871A2 (en) 2002-07-25
SV2003000849A (es) 2003-01-13
NO20033223D0 (no) 2003-07-16
MXPA03006408A (es) 2003-10-15
AP2002002401A0 (en) 2002-03-31
IL156087A0 (en) 2003-12-23
CA2435121A1 (en) 2002-07-25
CR6983A (es) 2003-11-25
DOP2002000325A (es) 2003-01-31
IS6818A (is) 2003-05-15
GT200200003A (es) 2002-08-19
MA26980A1 (fr) 2004-12-20
PL362793A1 (en) 2004-11-02
HUP0302767A2 (hu) 2003-11-28
OA12440A (en) 2006-05-22
BG107834A (bg) 2004-01-30
GB0101223D0 (en) 2001-02-28
ECSP034692A (es) 2003-08-29
PA8537101A1 (es) 2002-08-29
ZA200304180B (en) 2004-06-15
SK8572003A3 (en) 2004-07-07
JP2004517883A (ja) 2004-06-17
CN1486178A (zh) 2004-03-31
TNSN02003A1 (fr) 2005-12-23
AR032101A1 (es) 2003-10-22
EE200300335A (et) 2003-12-15
CZ20031853A3 (cs) 2004-07-14
EA200300537A1 (ru) 2004-02-26

Similar Documents

Publication Publication Date Title
EP1617832B1 (en) Compositions for affecting weight loss
TWI314054B (en) Novel methods and compositions for alleviating pain
TWI353835B (en) Novel methods for identifying improved, non-sedati
Barnes The role of anticholinergics in chronic obstructive pulmonary disease
Maesen et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group
US20070060638A1 (en) Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
KR20070036079A (ko) 성기능 장애에 관한 다중 제제 요법
JP2003525240A (ja) 糖尿病性腎障害の処置のためのpdgf受容体チロシンキナーゼ阻害剤の使用
KR20030069216A (ko) 히스타민 수용체 길항제
US20060276549A1 (en) Combination and use of drugs
JP2000198734A (ja) 胃運動性減弱および関連疾患の治療のための運動性増強薬
EP1387685B1 (en) Analgesic composition comprising an opioid and a sodium channel blocker
KR20060004959A (ko) 신장 기능 저하를 갖는 개별 대상자의 이뇨 작용 개선 방법
KR20050106038A (ko) 심장질환 및 신장질환의 치료를 위한 아데노신 a1 수용체길항제
AU3800601A (en) Treating allergic and inflammatory conditions
JP2003511410A (ja) 肥満症の治療のためのモルホリノール誘導体
US20020132755A1 (en) Histamine receptor antagonists
EP2227235B1 (en) Mequitazine for treating or preventing obstructive bronchopneumopaty involving histamine h4 receptors
US20210213001A1 (en) Method of treating a sleep breathing disorder
AU2002216328A1 (en) Histamine receptor antagonists
JP7433331B2 (ja) 特発性肺線維症を治療するための組成物及び方法
JP4243701B2 (ja) ベンズアミド誘導体を有効成分とするリウマチ治療薬
CA2517313A1 (en) Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
EP1374870A1 (en) Medication for the treatment or prevention of migraine
WO2018197638A1 (en) Novel use of (5r)-5-[5-[{2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl}(methyl)amino]-4-(4-fluoro-2-methylphenyl)-2-pyridinyl]-2-methyl-d-prolinamide

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application